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Abstract 
Previous work indicated that conformational changes of β-lactoglobulin (β-LG) 
induced by dynamic high pressure microfluidization (DHPM) was related to the 
increase of antigenicity. In this study, β-LG glycated with 1-kestose and combined 
with DHPM decreased the antigenicity of β-LG. The antigenicity of control, 
β-LG-kestose (0.1 MPa) and β-LG-kestose (80 MPa) were 100, 79 and 42 μg/mL 
respectively. The molecular weight of β-LG conjugated to kestose increased from 
18.4 to 19.6 kDa and its conformation scarcely changed. Conversely, combined with 
DHPM treatment (80 MPa), β-LG conjugated to kestose formed two conjugates with 
molecular weight of 18.8 and 19.8 kDa, respectively. Furthermore, the unfolding of 
β-LG as a result of the treatments is reflected by a decrease of intrinsic and 
synchronous fluorescence intensity and changes to the secondary structure. The 
conformational changes induced by DHPM and glycation treatments synergistically 
decrease the antigenicity of β-LG due to more masked or disrupted epitopes.  
Keywords:  β-lactoglobulin; 1-kestose; Antigenicity; Combined treatment; 
Modulation mechanism  
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1. Introduction 
The dairy protein, β-LG possesses lots of nutritive, biological and functional 
properties. However, the antigenicity of this protein limits their application in the food 
industry (Moro, Baez, Busti, Ballerini, & Delorenzi, 2011). Previous works have 
investigated the effect of various processing treatments on the antigenicity of β-LG, 
including dynamic high pressure microfluidization (DHPM) (Zhong, et al., 2012; 
Zhong, Luo, Liu, & Liu, 2014a), heat treatment (Zhong, et al., 2011), glycation 
(Zhong, Tu, Liu, Luo, & Liu, 2015; Zhong, et al., 2014b; Zhong, et al., 2013), and 
PEGylation (Zhong, et al., 2016). It was found that the increase in the antigenicity of 
β-LG was related to the conformational changes induced by DHPM treatment (Zhong, 
et al., 2012). On the contrary, it was observed that when conjugated with different 
saccharides the conformation of β-LG changed differently, but a similar decrease in 
antigenicity occurred (Zhong, et al., 2015). As two different modulated processes of 
antigenic response of β-LG, the mechanism of its antigenicity change is not 
completely clear when the protein undergo a combined treatment of glycation reaction 
and DHPM. 
Additionally, the type of saccharide used for glycation plays a significant role in 
the antigenicity changes of β-LG. Higher molecular weight of carboxymethyl dextran 
was more effective in declining the immunogenicity of β-LG (Kobayashi, et al., 2001). 
The antigenicity of β-LG conjugated with phosphoryl oligosaccharides was much 
lower than that conjugated with alginic acid oligosaccharide (Hattori, et al., 2004). 
However, there was no significant difference in the antigenicity decrease when β-LG 
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was conjugated with the two main components of fructo-oligosaccharides (FOS) - 
nystose and β-fructofuranosyl nystose (Zhong, et al., 2015). As per Kim, Lee, Go, 
Ahn, and Hong (2018), kestose, the smallest short-chain FOS, activates the gut 
immune system that induces tolerance against allergic skin inflammations in atopic 
dermatitis. However, there is no information describing how kestose modulates the 
antigenicity of β-LG.  Further, no studies have reported the combined effect of 
kestose glycation reaction and DHPM treatment on the antigenicity of β-LG which is 
investigated in this study.  
Previous research has reported DHPM at 80 MPa induces conformational 
changes in β-LG and therefore used in this study. The DHPM at 80 MPa was 
combined with and without kestonse glycation reaction to elucidate the mechanism of 
antigenicity changes of β-LG. In addition, the modulation mechanism was 
characterized by multi-spectroscopy, including Quadrupole Time-of-Flight (Q-TOF) 
LC/MS spectrometer, intrinsic fluorescence spectra, synchronous fluorescence spectra, 
and circular dichroism spectra that helps to determine the conformational changes of 
the protein. 
 
2. Materials and methods 
2.1 Materials 
Bovine β-LG standard (L3908), kestose (GF2) and anti-rabbit IgG (A6154) were 
obtained from Sigma Chemical Company (St. Louis, MO, USA). All other reagents 
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were of analytical grade or better.  
2.2 DHPM Combining with Glycation Treatment 
β-LG solutions (1 mg/mL) were treated at the atmospheric pressure (0.1 MPa) 
and pressure of 80 MPa in a dynamic high pressure microfluidizer processor (model 
M-110EH-30, Microfluidics, Newton, MA). Samples were collected and glycated 
with kestose immediately according to the methods of Zhong et al. (2015). All 
glycation experiments were performed in triplicate. β-LG heated at conjugate 
conditions without kestose (heated control) was named ‘‘β-LG (control)’’, and 
unprocessed β-LG-GF2 conjugate was named ‘‘β-LG-GF2 (0.1MPa)’’. Samples 
glycated with GF2 after DHPM treatment at 80MPa was named “β-LG- GF2 
(80MPa)”. 
2.3 Antigenicity analysis. 
The antigenicity of different samples was determined by an indirect competitive 
ELISA (Zhong, et al., 2015; Zhong, et al., 2014b). Polyclonal IgG antibodies of rabbit 
(bs-0814R, Bioss Co., Beijing, China), monospecific for β-LG, were applied, 
detecting the antigenic response of β-LG (Kleber, Krause, Illgner, & Hinrichs, 2004). 
The antigenic response of the β-LG samples was calculated from a standard curve of 
β-LG, for which a linear logarithmic correlation was observed in the range of 0.01 to 
400 μg/mL for β-LG. All analyses were carried out in triplicate, and the averaged 
values were converted to concentration equivalents in micrograms per milliliter 
(μg/mL). 
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2.4 Q-TOF mass spectrometry analysis. 
The method by Zhong et al. (2013) was used to investigate the molecular weight 
of different β-LG samples. Samples was analyzed using the Agilent 
6538-accurate-mass Quadrupole Time-of-Flight (Q-TOF) LC/MS spectrometer 
(Agilent Technologies, Waldbronn, Germany). Samples were diluted in a saturated 
solution of R-cycano-4-hydroxycinnamic acid in 0.1% TFA with 33% acetonitrile. An 
aliquot of this mixture was spotted onto a stainless steel target, air-dried, and 
subjected to mass determination (Medrano, Abirached, Panizzolo, Moyna, & Anon, 
2009). The monitored mass range was m/z 100-20,000. 
2.5 Circular dichroism spectroscopy analysis. 
Circular dichroism (CD) spectroscopy analyses were run for different samples 
according to Zhong et al. (2015). Far-UV CD spectra of samples at 0.1 mg/mL in 10 
mM sodium phosphate buffer, pH 7.0, were measured at 22 ºC using a MOS-450 
spectropolarimeter (French Bio-Logic SAS Co., Claix, French). Cylindrical quartz 
cuvette with path lengths of 0.1 cm was used for collecting data in the regions from 
190 to 250 nm. Scans were performed for each solution according to the following 
conditions: 100 nm/min scan rate, 1 nm step resolution, and 1.0 nm of bandwidth. 
Structure predictions from CD spectra were obtained using the Contin LL program (de 
la Hoz & Netto, 2008). 
2.6 Intrinsic fluorescence analysis. 
Fluorescence analyses were performed for all samples, as described by Zhong et 
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al. (2014 and 2015). Fluorescence spectra was measured in a Hitachi 
Spectro-fluorimeter F-4500 (Hitachi, Tokyo, Japan) using 10 mm square quartz cells. 
Protein concentration was 2 mg/mL in phosphate buffer (10 mM, pH 7.0). The 
excitation wavelength was 280 nm and the emission spectrum was scanned from 300 
to 450nm using a 5 nm bandwidth, excitation and emission slits of 2.5 and 5.0 nm, 
respectively, and a scan speed of 240 nm/min. 
2.7 Synchronous Fluorescence Spectra Analysis 
Synchronous fluorescence analyses were performed for different β-LG samples 
that were carried out in a Hitachi spectrofluorimeter (F-4500, Hitachi, Tokyo, Japan) 
using 10 mm quartz cells and a protein concentration of 0.15 mg/mL in phosphate 
buffer solution (10 mM, pH 7.0). The synchronous fluorescence spectra were obtained 
considering the wavelength intervals Δλ = 15 nm and Δλ = 60 nm to evidence the 
tyrosine and tryptophan residues, respectively (Δλ = λem - λex) (Varlan & Hillebrand, 
2010). 
2.8 Statistical analysis.  
The one-way ANOVA test for significant effects of treatments and assays was 
determined using SPSS 12.0.1 (SPSS Inc., Chicago, IL). Main effect differences were 
considered significant at P ≤ 0.05. Mean separations were determined by Tukey’s 
procedure for multiple comparisons. All experiments were analyzed in triplicate. 
 
3. Results and discussion  
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3.1 Changes in molecular weight 
The molecular weight of the β-LG-GF2 conjugates increased due to the 
formation of a covalent bond between the amino residue of protein and the reducing 
end of sugar. The molecular weight of β-LG is about 18.4 kDa that increased to 19.6 
kDa following conjugation with GF2 (Fig. 1). Only one conjugate was formed when 
β-LG was subjected to glycation. Interestingly, after the β-LG was pretreated by 
DHPM, two β-LG-GF2 (80 MPa) conjugates were formed, the molecular weight of 
which increased to 18.8 and 19.8 kDa, respectively (Fig. 2). Since the molecular 
weight of GF2 is 504 Da, therefore we conclude that the number of GF2 conjugated 
with β-LG in the three conjugations may be three, one and four, respectively. 
According to Chen et al. (2017), DHPM treatment could improve the glycation level, 
by forming more glycation sites via conformational changes of the protein. 
3.2 CD spectra analysis 
β-LG is a predominantly β-sheet protein, as per the CD spectra and the secondary 
structure content shown in Fig. 3. High amount of β-strands displayed in the CD 
spectra, is reflected by a negative extreme around 217 nm, a crossing zero dichroism 
around 204 nm, and a positive maximum around 195 nm. Similarly, the secondary 
structure of β-LG (control) was composed of 35.6% β-sheets, 14% α-helix, 21.8% 
turns, and 29.1% random coil. The spectrum of the β-LG-GF2 (0.1 MPa) displayed a 
little decrease in ellipticity compared with the control β-LG. Similar results were 
observed in a previous work where β-LG was conjugated with FOS (Zhong et al., 
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2013) and GF3 (Zhong et al., 2015). In addition, except for a significant increase in 
α-helix content, there were no obvious differences among the β-sheets, turns, and 
unordered contents. Some researchers observed a small alteration in the secondary 
structure of the protein after glycation (Hattori, et al., 2004; Wong, Day, & Augustin, 
2011). However, Liu et al. (2012) indicated that glycation increased the α-helix 
content. Based on the above results, we conclude that after conjugation with GF2 the 
secondary structure of β-LG slightly changed.  
Surprisingly, DHPM changed the glycation modification process. The spectrum 
of the β-LG-GF2 (80 MPa) displayed a notable increase in ellipticity and a shift of the 
negative maximums to a lower wavelength (from 217 nm to 213 nm) compared with 
that of β-LG-GF2 (0.1 MPa), accompanied by an increase in percentage content of 
β-sheets and unordered from 32.3% and 25% to 38.3% and 30.6%, respectively. 
Additionally, the α-helix content decreased from 21.5% to 9.97%. According to some 
researchers (Chen, et al., 2016; Zhong, et al., 2014b), when DHPM treated β-LG 
conjugates with galactose and GOS, the negative molar residue ellipticity peaks  
decreases. Chen et al. (2016) suggests that the effect of glycation combined with 
DHPM treatment on the secondary structure of β-LG depended on many factors, such 
as the sugar used, the level of glycation and so on. The secondary structure changes of 
β-LG glycated with GF2 combined with DHPM treatment in the current study were 
similar with the changes of β-LG-GOS under similar conditions (Zhong, et al., 2014b), 
while these changes were different from that conjugated with galactose combined 
with DHPM (Chen et al., 2016). β-LG consists of 9 antiparallel β-strands and 1 major 
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α-helix at the C terminus of the protein (Le Maux, Bouhallab, Giblin, Brodkorb, & 
Croguennec, 2014). The secondary structure changes of β-LG-GF2 (80 MPa) indicated 
that the combined treatments of DHPM and glycation induced the unfolding of 
protein, reflected by the increase of unordered content mainly at the expense of 
α-helix.  
3.3 Intrinsic fluorescence emission spectroscopy 
Intrinsic fluorescence of β-LG is mainly due to the excitation of the tryptophan 
(Trp) and tyrosine (Tyr) residues or some specific interactions between Trp and Tyr, 
affected by the surrounding environment and any alteration to the conformation (Chen 
et al., 2016 and Zhong et al., 2013). The fluorescence intensity of β-LG (control) was 
373.2. As shown in the Fig. 4a, the fluorescence spectrum of β-LG-GF2 (0.1 MPa) and 
β-LG (control) almost overlapped. A similar result was also observed when β-LG 
conjugated with phosphoryl oligosaccharides (Hattori et al., 2004). In contrast, when 
β-LG was glycated by FOS, GOS, GF3, and galactose, an obvious decrease of 
fluorescence intensity was displayed (Zhong et al., 2012, 2013, 2015; Chen et al., 
2016). The fluorescence intensity of β-LG-GF2 (0.1 MPa) was 374.9, slightly higher 
than that of control sample. In conclusion, the tertiary structure of β-LG was scarcely 
influenced by GF2 during the glycation treatment. After pretreatment at 80 MPa, the 
fluorescence intensity of β-LG-GF2 (80 MPa) noticeably declined to 69.98. Compared 
with β-LG (control), the fluorescence spectrum of β-LG-GF2 (80 MPa) showed a 
slight red shift in the maximum fluorescence emission wavelength. Liu et al. (2009) 
and Hattori et al. (2004) indicated that fluorescence intensity decreased and the shift 
  
11 
 
in fluorescence wavelength were due to the altered conformation around Trp or Tyr 
residues. Hence, we further investigated the synchronous fluorescence spectra 
changes of Trp and Tyr residues.  
3.4 Synchronous fluorescence spectroscopy 
According to Varlan and Hillebrand (2010), the synchronous fluorescence 
spectra were obtained considering the wavelength intervals Δλ = 15 nm and Δλ = 60 
nm that  indicates the tyrosine and tryptophan residues, respectively (Δλ = λem - 
λex). As shown in the Fig. 4b and 4c, the changes in the fluorescence spectra of Trp 
and Tyr residues were similar with the intrinsic fluorescence spectra of β-LG (Fig. 4a). 
The fluorescence spectrum of Tyr residues in β-LG-GF2 (0.1 MPa) and β-LG (control) 
almost overlapped completely (Fig. 4b). The fluorescence intensity of Trp and Tyr 
residues slightly increased from 618.0 and 1111 (control) to 674.7 and 1121 in the 
presence of GF2 without DHPM pretreatment. Similarly, the conformation around the 
Trp and Tyr residues remained unchanged. 
However, the intensity values of Trp and Tyr residues in β-LG-GF2 (80 MPa) 
sample decreased to 104.1 and 183.4 (Fig. 4c) respectively from 674.7 and 1121, 
similar to the results obtained with intrinsic fluorescence spectra of β-LG-GF2 (80 
MPa). It is well know that one β-LG molecule has two tryptophan residues (Trp19 
and Trp61), located at the bottom of the calyx and close to the entrance of calyx, and 
four Tyr residues at positions 20, 42, 99, and 102 (Keppler, Sonnichsen, Lorenzen, & 
Schwarz, 2014). Tyr20 and Tyr42 are located in the groove between the β-strand B 
and helical turn 153-157, and Tyr102 is located in the groove between the α-helix and 
  
12 
 
the β-barrel. It was reported that the carbohydrate-binding sites in the β-LG were 
mainly identified in residue Lys (Hattori et al., 2004). In addition, Chen et al. (2017) 
indicated DHPM could improve the glycation level and changed the glycation sites 
induced by the alteration of conformation. The decrease of fluorescence intensity in 
the case of β-LG-GF2 (80 MPa) was considered to be due to a masking influence by 
GF2 chain bound to Lys60, 100, or 101 in the conjugate.  
3.5 Antigenicity analysis 
FOS is a mixture of oligosaccharides, consisting of different structures including 
1
F
-(1-β-fractofranosyl)n-1 sucrose; such as, 1-kestose (n=2, GF2), nystose (n=3, GF3), 
1
F
-β-fractofranosyl nystose (n=4, GF4). In previous studies, we observed that the 
conjugation of FOS, GF3 and GF4 significantly declined the antigenicity of β-LG 
(Zhong et al., 2013 and 2015). A similar result was obtained with GF2. From Fig. 5 it 
is clear that the antigenicity of the control β-LG was 100 μg/mL. After the glycation 
treatment with GF2, an obvious decrease in the antigenicity of β-LG was observed (p 
< 0.05) with antigenicity value of β-LG-GF2 (0.1 MPa) being 79 μg/mL. Compared to 
our previous results (Zhong et al., 2013 and 2015), the rate of decline in the 
antigenicity of β-LG-GF2 (21%) was far lower than that of β-LG-FOS (81.5%), 
β-LG-GF3 (79.4%) and β-LG-GF4 (78.0%). Therefore, due to the different nature of 
saccharides, it can be said that GF2 was not the main component in the FOS affecting 
directly the antigenicity of β-LG.  
Interestingly, we found that DHPM and glycation treatments have a synergistic 
effect on the decrease of antigenicity. After pre-treated by DHPM, the antigenicity of 
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β-LG-GF2 (80 MPa) further declined to 42 μg/mL from 79 μg/mL, which was 
approximately half of β-LG-GF2 (0.1 MPa). Similar results were obtained by Zhong et 
al. (2014b) and Chen et al. (2016). Zhong et al., (2012) and Zhong et al., (2013) 
indicate that not only the conformational changes of protein during treatments but also 
the glycation process affected by nature of saccharides both influence the decrease in 
antigenicity of β-LG. Zhong et al., (2015) also observed that different conformational 
changes in β-LG during the glycation treatment could result in a similar decrease in 
antigenicity. Then the obvious question arises as to what happens to the antigenicity 
of β-LG during a combined treatment of DHPM and glycation.  
The antigenicity of β-LG is related to the 3D structure of protein, depended on 
the conformational epitopes and the linear epitopes (Kleber, et al., 2004). As shown in 
Fig. 6, although the conformation of β-LG barely changed when conjugated with GF2, 
the decline in the antigenicity was mostly due to the epitopes masked or disrupted by 
GF2 during the glycation treatment. As Chen et al. (2017) indicated, DHPM treatment 
could improve the glycation level and change the glycation sites. After DHPM 
pretreatment, an additional glycated site (Lys 60) was observed in the β-LG. Similar 
results were also observed in this current study. The unfolding of β-LG induced by 
DHPM contributed to exposure of more reactive sites (e. g. Lys60), as reflected by the 
fluorescence spectra results and the molecular weight changes, and subsequently 
resulted in two different conjugates. And the number of GF2 in one conjugate was one 
more than that of β-LG-GF2 (0.1 MPa). Zhang et al. (2014) suggested that when the 
main epitopes were glycated, the antigenicity declined the most. Similarly, the best 
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recognized epitope AA41-60 may be shielded or disrupted by the conjugation, 
resulting in reducing the antigenicity obtained in this study. Furthermore, the epitopes 
AA41-60 and AA102-124 form a protruding loop between β-strands C and D on the 
surface of the molecule (Wal, 2001). Also, the β-sheets of β-LG include certain 
epitopes, particularly two very conformation-sensitive epitopes (Clement, et al., 2002). 
During the coupled treatments, the changes of β-sheets could influence those epitopes 
and contribute to less antigenicity. Previous research has reported that the 
conformational changes of β-LG maybe directly related to its antigenicity. For 
example, the unfolding of β-LG induced by DHPM at 80 MPa contributed to exposure 
of some hidden epitopes that eventually increased the antigenicity (Zhong et al, 2012). 
Some researchers also suggest that conformational changes could affect the glycation 
degree and site, and eventually impact the antigenicity of protein (Zhang et al., 2014; 
Chen et al., 2017). In conclusion, in the current study, conformational changes 
induced by DHPM and the glycation process have a synergistic effect on the decline 
of antigenicity, mainly due to masking or disruptions of the important epitopes.   
 
4. Conclusions 
In this study it was observed that conformational changes induced by DHPM and 
the glycation process together have a synergistic effect on the decrease of antigenicity 
of β-LG. During the glycation treatment without DHPM, one type of conjugates was 
formed. A decline in the antigenicity of β-LG-GF2 without DHPM treatment mainly 
resulted from epitopes masked or disrupted by GF2, with hardly any changes to the 
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conformation of protein. On the other hand, two types of conjugates were obtained 
after glycation combined with DHPM treatment. During the combined treatment of 
DHPM and glycation, the unfolding of β-LG induced by DHPM contributed to more 
epitopes being masked or disrupted by GF2, resulting in further decline in the 
antigenicity of β-LG. 
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Figure Captions: 
Figure 1. The Q-TOF/Mass spectrum of β-LG-GF2 (0.1 MPa). 
Figure 2. The Q-TOF/Mass spectrum of β-LG-GF2 (80 MPa). 
Figure 3. CD spectra analysis and the percentage content of secondary structures of 
β-LG (control), β-LG-GF2 (0.1 MPa) and β-LG-GF2 (80 MPa). 
Figure 4. a. Intrinsic fluorescence spectroscopic analysis of β-LG (control), 
β-LG-GF2 (0.1 MPa) and β-LG-GF2 (80 MPa); b. Synchronous fluorescence spectrum 
of tryptophan residues in the β-LG (control), β-LG-GF2 (0.1 MPa) and β-LG-GF2 (80 
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MPa), λ = 60 nm; c. Synchronous fluorescence spectrum of tyrosine residues in the 
β-LG (control), β-LG-GF2 (0.1 MPa) and β-LG-GF2 (80 MPa), λ = 15 nm. 
Figure 5. The antigenicity of β-LG (control), β-LG-GF2 (0.1 MPa), β-LG-GF2 (80 
MPa). 
a-c
Different letters denote significant differences across different treatments 
(P≤0.05) 
Figure 6. A model of the initial modulation mechanism
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Highlights 
 Antigenicity of conjugate formed at 80 MPa was half the value of that under 0.1 
MPa 
 One conjugate formed using 0.1 MPa and its conformation scarcely changed. 
 Two conjugates formed using 80 MPa and the unfolding of their conformation 
occurred 
 Two treatments have a synergistic effect on the decrease of its antigenicity.  
 
 
